Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Plast Reconstr Aesthet Surg ; 85: 202-209, 2023 10.
Artigo em Inglês | MEDLINE | ID: mdl-37524032

RESUMO

BACKGROUND: Enhanced recovery after surgery (ERAS) programs are associated with improved management, reduced hospital stays, and lower complication rates. OBJECTIVE: To evaluate the impact of ERAS on mean length of stay (LOS) and postoperative morbidity in breast reconstruction with latissimus dorsi flap (LDF) compared with conventional recovery program. PATIENTS AND METHOD: All patients operated by LDF between December 2014 and October 2020: those managed before April 2018, when the ERAS protocol was introduced, were included in the "no ERAS" group, and beyond in the "ERAS" group. RESULTS: Out of 193 patients, 129 were included in the "ERAS" group and 64 in the "no ERAS" group. There was a significant difference between the two groups in LOS (4.2 ± 1.5 days in the "ERAS" group vs. 5.4 ± 1.9 days in the "no ERAS" group; p < 0.001), high-grade complications at 30 days (9.3% in the "ERAS" group vs. 25% in the "no ERAS" group; p = 0.01), reintervention rate (13.9% vs. 26.6%, respectively; p = 0.02), and 30-day rehospitalization rate (6.2% in the "ERAS" group vs. 15.6% in the "no ERAS" group; p = 0.03). CONCLUSION: The ERAS protocol has a positive impact on breast reconstruction with LDF without generating additional adverse effects. These results support the democratization of these programs for breast reconstruction surgery.


Assuntos
Recuperação Pós-Cirúrgica Melhorada , Mamoplastia , Músculos Superficiais do Dorso , Humanos , Músculos Superficiais do Dorso/transplante , Complicações Pós-Operatórias/etiologia , Mamoplastia/métodos , Retalhos Cirúrgicos , Tempo de Internação , Estudos Retrospectivos
2.
Pharmazie ; 60(7): 524-6, 2005 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16076079

RESUMO

The rate and extent of drug release from the most controlled release wax matrices are influenced by the drug loading/embedding excipient ratio of the systems. In the present study hydrophobic wax - zinc sulphate matrices with different drug loadings were prepared for the therapy of Wilson's disease. The drug release was tested by the paddle method of USP and the dissolution data were analysed. Both the dissolution rate and kinetic profile can be controlled by alteration in the quantity of embedding material. Matrices of 75% zinc sulphate loadings showed steady state diffusion-controlled matrix release with good correlation in vitro. Good absorption of zinc sulphate from the gastrointestinal tract was proven by significant elevation of serum zinc level in patients with Wilson's disease.


Assuntos
Degeneração Hepatolenticular/tratamento farmacológico , Sulfato de Zinco/administração & dosagem , Sulfato de Zinco/uso terapêutico , Absorção , Algoritmos , Cápsulas , Química Farmacêutica , Excipientes , Cinética , Lipídeos/química , Modelos Químicos , Porosidade , Solubilidade , Ceras , Sulfato de Zinco/química
3.
Fitoterapia ; 76(2): 166-72, 2005 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15752626

RESUMO

The transfer through a membrane of the main organic components and mineral elements of Carum carvi and Foeniculum vulgare volatile oils was studied. The transfer was studied from buffer solution pH 1.1 (stomach) and pH 6.5 (intestine) to pH 7.5 (plasma) in a Sartorius model. The transferred components were measured by GC-MS for volatile components and ICP-OES for inorganic elements. The main components (trans-anethole and fenchone from F. vulgare, carvone and D-limonene from C. carvi), as well as some mineral elements (Ca, Mg, S, Zn), transferred through the membrane.


Assuntos
Carum , Foeniculum , Mucosa Gástrica/metabolismo , Mucosa Intestinal/metabolismo , Fitoterapia , Óleos de Plantas/farmacocinética , Cromatografia Gasosa-Espectrometria de Massas , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...